Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@Madhav
I am in a similar position as you, i do believe that if the approvals come the SP will rise. My own guess is around 20% on FDA. But please dont take my word for it. Its just a guess. Others believe a 10% raise is more appropriate.
There is no such thing as deramping, nothing to be afraid of, speak your mind, ask anything you like. Just remember the names of the rampers, only a few left now. Any replies from them, treat them with the suspicion they deserve.
Back to your question, i believe two things have happened here.
The covid bubble was massive, and at the time we bought in, everything was 100% on any news. The downside was we bought in at a price which is at odds with the 'current' value. Will we get to 300p - not any time soon is my opinion, ask others and see what they think, just not the rampers.
The second issue is maybe the company or the rampers on here led people like us to believe GDR were ahead of the game, except there weren't. The fact that its taken them nearly 2 months following CE and we still dont have approvals probably shows that GDR were shortsighted, naive, hedged all their bets for the NHS etc etc heck they only tried to recruit someone two weeks ago on a 3 month contract, whilst all their competitors are recruiting senior positions full time. It could also be GDR just plain didnt have a fully market ready test package or the test results which work on an open source system didnt work like expected and this caused bigger issues than DB let on (DB admitted to this). I am not going to say us investors misinterpreted the company position in the market place because NCYT has made sales, ODX have made a small 100k sale. Globally lots of Covid companies are making sales.
I would think all regulatory bodies in all countries are completely swamped with 100x more products being processed than usual so lead times will be affected and in reality it could now take a month+ whereas it would have been 2 weeks prior to Covid19.
@Madhav
Some African countries will accept CE for sales
Why did they not apply for India direct.? Rather than take the FDA roue to get to India.
Product has been ready for a while. They would have the approval by now imoh
Omega is not cleared to sell in India they have not recieved regulatory approval.
No, Omega are not clear to sell, they have pre-authorisation that hey can sell once they show performance data for their test, actually until then they can not sell. It was a very strange RNS, typically you announce once you have full authorisation not that you've entered the process. Odd.
No Omega is cleared to sell in India, GDR isnt, a similar post was also posted there.
so was the query about omega or GDR approval in india?
Sorry... Getting confused with my Omegas and my Genedrives.....
why the omega pr link?
Cost is between £25 and £30 per test
I know the indian market very very well. This is still very expensive for the average indian national. Allow me to put it into context. A good above average salary is about £100 per week. To get a family of 4 tested, its a weeks wages. To put it into UK context, its like costing us £500 for 4 tests based on avg UK salary.
India is a big market, no doubt, but dont let anyone fool you saying all of india is up for grabs. This is the same for all Covid companies wishing to sell in India not specific to GDR.
Is the test officially approved in India, yes or no? RNS released last week is contradictory in its articulation. Simple question, the RNS is in the public domain.
The simple answer is "Yes". Please note that we do not normally respond to investor enquiries via Twitter so please email us on omega@walbrookpr.com if you have further queries.
Fixed costs for anyone who wants a test in India. This is NOT a ramp, we dont have approval to sell in India yet.
https://www.livemint.com/news/india/mumbai-allows-covid-19-testing-for-all-no-doctor-s-prescription-needed-11594143069721.html